More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Abstract

COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systematic review and meta-analysis aims to identify studies assessing the long-term effects of COVID-19. LitCOVID and Embase were searched to identify articles with original data published before the 1st of January 2021, with a minimum of 100 patients. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. PRISMA guidelines were followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included (age 17–87 years). The included studies defined long-COVID as ranging from 14 to 110 days post-viral infection. It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). Multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.

Cited by papers we hold 31

• Do we need coronavirus vaccination today? · 2023
  Not checked
• Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program · 2023
  No notice
• Rheumatoid arthritis and COVID-19: Three years later · 2023
  Not checked
• Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post–COVID-19 Condition · 2023
  No notice
• Biomarkers in long COVID-19: A systematic review · 2023
  No notice
• Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID · 2023
  No notice
• Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies · 2022
  Not checked
• Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study · 2022
  Not checked
• A causal learning framework for the analysis and interpretation of COVID-19 clinical data. · 2022
  Not checked
• Orthostatic Intolerance in Adults Reporting Long COVID Symptoms Was Not Associated With Postural Orthostatic Tachycardia Syndrome · 2022
  Not checked
• Post-acute COVID-19 condition in Saudi Arabia: A national representative study · 2022
  Not checked
• Prevalence and clinical presentation of long COVID in children: a systematic review · 2022
  No notice
• Long-COVID in children and adolescents: a systematic review and meta-analyses · 2022
  No notice
• Neuropsychiatric aspects of long COVID : A comprehensive review · 2022
  No notice
• Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis · 2022
  No notice
• Long COVID headache · 2022
  No notice
• Persistent COVID-19 symptoms in a community study of 606,434 people in England · 2022
  No notice
• Symptoms and risk factors for long COVID in non-hospitalized adults · 2022
  No notice
• Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) · 2022
  No notice
• Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study · 2022
  No notice

and 11 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.